A. Arnsten

Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task

A. Arnsten, A. Arnsten, T. Contant, 2005, Psychopharmacology.

Behavioral and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 [2-imidazoline-2-yl-amino]quinoxaline): evidence for cognitive enhancement at an α-2 adrenoceptor subtype.

A. Arnsten, 1991 .

Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling

A. Arnsten, 2008, Psychopharmacology.

Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys

P. Goldman-Rakic, J. Steere, A. Arnsten, 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes

P. Goldman-Rakic, J. Cai, A. Arnsten, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Mania: a rational neurobiology

H. Manji, A. Arnsten, 2008 .

Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype.

A. Arnsten, F. Leslie, 1991, Neuropharmacology.

Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype

A. Arnsten, F. Leslie, F. M. Leslie, 1991, Neuropharmacology.